Vaxart to Participate in Fireside Chat at 2023 Cantor Global Healthcare Conference
21 Setembro 2023 - 9:00AM
Vaxart, Inc. (Nasdaq: VXRT) today announced that senior management
will participate in a fireside chat at the 2023 Cantor Global
Healthcare Conference in New York on Thursday, September 28, 2023
at 2:25 p.m. ET.
The webcast of the fireside chat will be
available on the Company’s Investor Presentations & Events
page. A replay will be available on the Company’s website following
the event.
Management will also participate in one-on-one
meetings during the conference. Investors interested in a meeting
should contact their Cantor representative.
About VaxartVaxart is a
clinical-stage biotechnology company developing a range of oral
recombinant vaccines based on its proprietary delivery platform.
Vaxart vaccines are designed to be administered using pills that
can be stored and shipped without refrigeration and eliminate the
risk of needle-stick injury. Vaxart believes that its proprietary
pill vaccine delivery platform is suitable to deliver recombinant
vaccines, positioning the company to develop oral versions of
currently marketed vaccines and to design recombinant vaccines for
new indications. Vaxart’s development programs currently include
pill vaccines designed to protect against norovirus, coronavirus,
seasonal influenza, and respiratory syncytial virus (RSV), as well
as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s
first immune-oncology indication. Vaxart has filed broad domestic
and international patent applications covering its proprietary
technology and creations for oral vaccination using adenovirus and
TLR3 agonists.
Contacts
Vaxart Media Relations: |
|
Investor Relations: |
Mark Herr |
|
Andrew Blazier |
Vaxart, Inc. |
|
FINN Partners |
mherr@vaxart.com |
|
IR@vaxart.com |
(203) 517-8957 |
|
(646)
871-8486 |
Vaxart (NASDAQ:VXRT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Vaxart (NASDAQ:VXRT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024